

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 6.84575276 |
| 2 | endothelium development (GO:0003158) | 6.18476676 |
| 3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.68937974 |
| 4 | cardiac myofibril assembly (GO:0055003) | 5.30808568 |
| 5 | plasma membrane fusion (GO:0045026) | 5.30715318 |
| 6 | heart trabecula formation (GO:0060347) | 5.25422125 |
| 7 | sarcomere organization (GO:0045214) | 5.12274960 |
| 8 | wound healing, spreading of epidermal cells (GO:0035313) | 5.11868437 |
| 9 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.09348183 |
| 10 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.91761336 |
| 11 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.85986483 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.62299712 |
| 13 | positive regulation of vasculogenesis (GO:2001214) | 4.61899586 |
| 14 | angiogenesis involved in wound healing (GO:0060055) | 4.61108555 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.52976986 |
| 16 | myofibril assembly (GO:0030239) | 4.52658954 |
| 17 | plasma membrane repair (GO:0001778) | 4.50997005 |
| 18 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.36578091 |
| 19 | endothelial cell proliferation (GO:0001935) | 4.31852478 |
| 20 | fatty acid transmembrane transport (GO:1902001) | 4.17069944 |
| 21 | lymphangiogenesis (GO:0001946) | 4.16252075 |
| 22 | endothelial cell morphogenesis (GO:0001886) | 4.16092684 |
| 23 | regulation of sarcomere organization (GO:0060297) | 4.15048271 |
| 24 | blood vessel maturation (GO:0001955) | 4.12463182 |
| 25 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.11690922 |
| 26 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.11477857 |
| 27 | regulation of vasculogenesis (GO:2001212) | 4.06412566 |
| 28 | carnitine shuttle (GO:0006853) | 4.05470117 |
| 29 | regulation of endothelial cell differentiation (GO:0045601) | 4.03329466 |
| 30 | acrosome reaction (GO:0007340) | 4.01127336 |
| 31 | sprouting angiogenesis (GO:0002040) | 3.99365949 |
| 32 | morphogenesis of an endothelium (GO:0003159) | 3.92794158 |
| 33 | endothelial tube morphogenesis (GO:0061154) | 3.92794158 |
| 34 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.92541443 |
| 35 | regulation of actin filament-based movement (GO:1903115) | 3.89292870 |
| 36 | glomerular filtration (GO:0003094) | 3.89079459 |
| 37 | artery development (GO:0060840) | 3.86547489 |
| 38 | patterning of blood vessels (GO:0001569) | 3.85058419 |
| 39 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.84145087 |
| 40 | tricarboxylic acid cycle (GO:0006099) | 3.81059063 |
| 41 | actin-myosin filament sliding (GO:0033275) | 3.75325818 |
| 42 | muscle filament sliding (GO:0030049) | 3.75325818 |
| 43 | hyaluronan catabolic process (GO:0030214) | 3.73640545 |
| 44 | basement membrane organization (GO:0071711) | 3.73462537 |
| 45 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.72498293 |
| 46 | cardiac muscle contraction (GO:0060048) | 3.70441437 |
| 47 | surfactant homeostasis (GO:0043129) | 3.66816482 |
| 48 | renal filtration (GO:0097205) | 3.66139049 |
| 49 | sperm motility (GO:0030317) | 3.64376565 |
| 50 | cardiac muscle cell development (GO:0055013) | 3.60838555 |
| 51 | venous blood vessel morphogenesis (GO:0048845) | 3.58935911 |
| 52 | regulation of sequestering of triglyceride (GO:0010889) | 3.57164871 |
| 53 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.53691288 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.52827371 |
| 55 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.51448505 |
| 56 | endothelial cell differentiation (GO:0045446) | 3.50636343 |
| 57 | embryonic heart tube development (GO:0035050) | 3.50318506 |
| 58 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.47867464 |
| 59 | muscle tissue morphogenesis (GO:0060415) | 3.47040151 |
| 60 | cardiac cell development (GO:0055006) | 3.46681789 |
| 61 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.45274207 |
| 62 | response to pheromone (GO:0019236) | 3.45133516 |
| 63 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.44866782 |
| 64 | positive regulation of urine volume (GO:0035810) | 3.43454792 |
| 65 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.40884763 |
| 66 | actomyosin structure organization (GO:0031032) | 3.40614469 |
| 67 | regulation of cardioblast differentiation (GO:0051890) | 3.39136770 |
| 68 | trabecula formation (GO:0060343) | 3.36245699 |
| 69 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.36044152 |
| 70 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.34487005 |
| 71 | cardiac muscle hypertrophy (GO:0003300) | 3.33112437 |
| 72 | blood vessel endothelial cell migration (GO:0043534) | 3.32430719 |
| 73 | regulation of establishment of cell polarity (GO:2000114) | 3.30543217 |
| 74 | adult heart development (GO:0007512) | 3.29399282 |
| 75 | vasculogenesis (GO:0001570) | 3.28779450 |
| 76 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.26392545 |
| 77 | low-density lipoprotein particle clearance (GO:0034383) | 3.24107554 |
| 78 | striated muscle hypertrophy (GO:0014897) | 3.19444814 |
| 79 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.19181326 |
| 80 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.18168746 |
| 81 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.15903312 |
| 82 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.15513371 |
| 83 | cell communication involved in cardiac conduction (GO:0086065) | 3.15370664 |
| 84 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.14073345 |
| 85 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.12029484 |
| 86 | cardiac muscle cell proliferation (GO:0060038) | 3.08672348 |
| 87 | actin-mediated cell contraction (GO:0070252) | 3.08372536 |
| 88 | chemical homeostasis within a tissue (GO:0048875) | 3.05414231 |
| 89 | regulation of synapse maturation (GO:0090128) | 3.05386919 |
| 90 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.04526597 |
| 91 | carnitine transmembrane transport (GO:1902603) | 3.03550370 |
| 92 | cell communication by electrical coupling (GO:0010644) | 3.03190353 |
| 93 | negative regulation of endothelial cell migration (GO:0010596) | 3.01245326 |
| 94 | cellular ketone body metabolic process (GO:0046950) | 3.00753261 |
| 95 | positive regulation of receptor recycling (GO:0001921) | 2.99794468 |
| 96 | regulation of striated muscle contraction (GO:0006942) | 2.99197461 |
| 97 | anatomical structure maturation (GO:0071695) | 2.97819949 |
| 98 | establishment of protein localization to Golgi (GO:0072600) | 2.97219333 |
| 99 | transcytosis (GO:0045056) | 2.97022779 |
| 100 | nephron epithelium development (GO:0072009) | 2.96955108 |
| 101 | gap junction assembly (GO:0016264) | 2.95932823 |
| 102 | heart trabecula morphogenesis (GO:0061384) | 2.95721347 |
| 103 | * regulation of the force of heart contraction (GO:0002026) | 2.93349805 |
| 104 | regulation of relaxation of muscle (GO:1901077) | 2.93287620 |
| 105 | regulation of membrane repolarization (GO:0060306) | 2.92577441 |
| 106 | fatty acid beta-oxidation (GO:0006635) | 2.91735850 |
| 107 | regulation of skeletal muscle contraction (GO:0014819) | 2.91594636 |
| 108 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.89127152 |
| 109 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.88775329 |
| 110 | multicellular organism reproduction (GO:0032504) | 2.88227900 |
| 111 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.88211549 |
| 112 | cardiac muscle cell action potential (GO:0086001) | 2.85367897 |
| 113 | protein kinase C signaling (GO:0070528) | 2.83801201 |
| 114 | protein targeting to Golgi (GO:0000042) | 2.82781929 |
| 115 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.82307107 |
| 116 | regulation of p38MAPK cascade (GO:1900744) | 2.82053223 |
| 117 | carnitine transport (GO:0015879) | 2.80991947 |
| 118 | amino-acid betaine transport (GO:0015838) | 2.80991947 |
| 119 | platelet dense granule organization (GO:0060155) | 2.80781998 |
| 120 | coronary vasculature morphogenesis (GO:0060977) | 2.80700666 |
| 121 | regulation of urine volume (GO:0035809) | 2.79662350 |
| 122 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.79001619 |
| 123 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.77638057 |
| 124 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.77551975 |
| 125 | negative regulation of epithelial cell migration (GO:0010633) | 2.77524961 |
| 126 | muscle hypertrophy (GO:0014896) | 2.77510645 |
| 127 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.77046994 |
| 128 | regulation of fatty acid oxidation (GO:0046320) | 2.76372052 |
| 129 | 2-oxoglutarate metabolic process (GO:0006103) | 2.74103458 |
| 130 | * angiogenesis (GO:0001525) | 2.73307362 |
| 131 | cardiac muscle adaptation (GO:0014887) | 2.72982163 |
| 132 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.72982163 |
| 133 | muscle hypertrophy in response to stress (GO:0003299) | 2.72982163 |
| 134 | trabecula morphogenesis (GO:0061383) | 2.72804359 |
| 135 | biotin metabolic process (GO:0006768) | 2.70718273 |
| 136 | protein polyglutamylation (GO:0018095) | 2.69126596 |
| 137 | positive regulation of protein kinase C signaling (GO:0090037) | 2.68589519 |
| 138 | negative regulation of adherens junction organization (GO:1903392) | 2.63918503 |
| 139 | negative regulation of focal adhesion assembly (GO:0051895) | 2.63918503 |
| 140 | negative regulation of cell junction assembly (GO:1901889) | 2.63918503 |
| 141 | negative regulation of angiogenesis (GO:0016525) | 2.61687529 |
| 142 | regulation of endothelial cell migration (GO:0010594) | 2.59937174 |
| 143 | negative regulation of protein autophosphorylation (GO:0031953) | 2.59166831 |
| 144 | facial nerve structural organization (GO:0021612) | 2.58140013 |
| 145 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.57846492 |
| 146 | glomerular visceral epithelial cell development (GO:0072015) | 2.56292656 |
| 147 | ketone body metabolic process (GO:1902224) | 2.56000161 |
| 148 | renal absorption (GO:0070293) | 2.54996183 |
| 149 | protein localization to Golgi apparatus (GO:0034067) | 2.54528195 |
| 150 | ganglion development (GO:0061548) | 2.53285559 |
| 151 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.53203872 |
| 152 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.52853057 |
| 153 | wound healing, spreading of cells (GO:0044319) | 2.52155946 |
| 154 | definitive hemopoiesis (GO:0060216) | 2.49360491 |
| 155 | cardiac muscle tissue development (GO:0048738) | 2.46294242 |
| 156 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.44091780 |
| 157 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43819379 |
| 158 | pharyngeal system development (GO:0060037) | 2.42760848 |
| 159 | atrial cardiac muscle cell action potential (GO:0086014) | 2.41273414 |
| 160 | heparin biosynthetic process (GO:0030210) | 2.39433676 |
| 161 | heparin metabolic process (GO:0030202) | 2.39433676 |
| 162 | alanine transport (GO:0032328) | 2.39293100 |
| 163 | negative regulation of vasculature development (GO:1901343) | 2.37253746 |
| 164 | cAMP biosynthetic process (GO:0006171) | 2.37061121 |
| 165 | NAD biosynthetic process (GO:0009435) | 2.36524402 |
| 166 | response to misfolded protein (GO:0051788) | 2.36513149 |
| 167 | organic cation transport (GO:0015695) | 2.32217552 |
| 168 | ear development (GO:0043583) | 2.31305090 |
| 169 | endothelial cell chemotaxis (GO:0035767) | 2.31071407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.51851099 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.26095426 |
| 3 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.24447010 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.20192582 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.14956427 |
| 6 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.84811911 |
| 7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.75444237 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.72091293 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.55106554 |
| 10 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.54455589 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.54455589 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54272920 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.24833912 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15892874 |
| 15 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.12289480 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10123130 |
| 17 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.90086088 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89895526 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89439117 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86070823 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85842293 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79778914 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78294988 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75898788 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75835276 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.75788913 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71296668 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.70365350 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.69564664 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68370572 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66227606 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61565292 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60039606 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59684910 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58046323 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55765493 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53184630 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.48680086 |
| 39 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.46201296 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44938883 |
| 41 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44791957 |
| 42 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43199003 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43199003 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41687725 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40965862 |
| 46 | ERA_21632823_ChIP-Seq_H3396_Human | 1.36075232 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35097380 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.34399476 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32944333 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32805554 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31975946 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31766367 |
| 53 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.29861145 |
| 54 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29119569 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28675271 |
| 56 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.27955427 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27837231 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27621738 |
| 59 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.27009441 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26593832 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26291514 |
| 62 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.25433602 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24323629 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24010391 |
| 65 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.23916237 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23609253 |
| 67 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.23507343 |
| 68 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23085574 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22638131 |
| 70 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22382601 |
| 71 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22318361 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20965168 |
| 73 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20688371 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20541489 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20394508 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20168628 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19488031 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19488031 |
| 79 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19297367 |
| 80 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19096480 |
| 81 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.18721048 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18332997 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16847768 |
| 84 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16371213 |
| 85 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15058087 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.15054162 |
| 87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14966455 |
| 88 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14652534 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14242473 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14119024 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13606431 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13585080 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12524936 |
| 94 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11954151 |
| 95 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.11572218 |
| 96 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.11520568 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11160354 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11043087 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10816848 |
| 100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10617382 |
| 101 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.10589596 |
| 102 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10263701 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09422561 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08313968 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07506147 |
| 106 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07416982 |
| 107 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06999431 |
| 108 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.06627825 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05335396 |
| 110 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04908655 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04742463 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03438990 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03165743 |
| 114 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.03030535 |
| 115 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.02843964 |
| 116 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02312872 |
| 117 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02103817 |
| 118 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01579070 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01451119 |
| 120 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00587591 |
| 121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00179450 |
| 122 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99871892 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99793989 |
| 124 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98750864 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98478791 |
| 126 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98171058 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98171058 |
| 128 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97898171 |
| 129 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97677954 |
| 130 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97274804 |
| 131 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97241920 |
| 132 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96821224 |
| 133 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.96515907 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96360104 |
| 135 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.96322091 |
| 136 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.96213983 |
| 137 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96100423 |
| 138 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96029266 |
| 139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95497703 |
| 140 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.95139666 |
| 141 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94899169 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94805168 |
| 143 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94766666 |
| 144 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94696218 |
| 145 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94012004 |
| 146 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93762122 |
| 147 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93451843 |
| 148 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.93117195 |
| 149 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92190269 |
| 150 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92010048 |
| 151 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91849317 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91287464 |
| 153 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90863791 |
| 154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89980331 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89777710 |
| 156 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88677200 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88653702 |
| 158 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88243069 |
| 159 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87197239 |
| 160 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.87160930 |
| 161 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.86521850 |
| 162 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85711064 |
| 163 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85711064 |
| 164 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84861364 |
| 165 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84267234 |
| 166 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84207751 |
| 167 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82726618 |
| 168 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.82670970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.04492384 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 4.54314439 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.52219328 |
| 4 | * MP0004084_abnormal_cardiac_muscle | 4.14704543 |
| 5 | MP0004272_abnormal_basement_membrane | 3.94627528 |
| 6 | MP0000751_myopathy | 3.62556229 |
| 7 | * MP0004215_abnormal_myocardial_fiber | 3.47077019 |
| 8 | * MP0005167_abnormal_blood-brain_barrier | 3.37449588 |
| 9 | MP0005330_cardiomyopathy | 3.12691999 |
| 10 | MP0003828_pulmonary_edema | 3.05735498 |
| 11 | * MP0004036_abnormal_muscle_relaxation | 2.90296770 |
| 12 | MP0005670_abnormal_white_adipose | 2.79602582 |
| 13 | MP0006138_congestive_heart_failure | 2.75642952 |
| 14 | MP0003646_muscle_fatigue | 2.71763248 |
| 15 | MP0004130_abnormal_muscle_cell | 2.49906198 |
| 16 | MP0000749_muscle_degeneration | 2.40563752 |
| 17 | * MP0002972_abnormal_cardiac_muscle | 2.38219999 |
| 18 | * MP0005410_abnormal_fertilization | 2.35602679 |
| 19 | * MP0001544_abnormal_cardiovascular_syste | 2.26088891 |
| 20 | * MP0005385_cardiovascular_system_phenoty | 2.26088891 |
| 21 | MP0010630_abnormal_cardiac_muscle | 2.22416645 |
| 22 | MP0004484_altered_response_of | 2.20634830 |
| 23 | MP0004087_abnormal_muscle_fiber | 2.15871267 |
| 24 | MP0002933_joint_inflammation | 2.14143490 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 2.07599306 |
| 26 | * MP0005620_abnormal_muscle_contractility | 2.06655076 |
| 27 | MP0000750_abnormal_muscle_regeneration | 2.03616065 |
| 28 | * MP0008775_abnormal_heart_ventricle | 2.01777037 |
| 29 | MP0000013_abnormal_adipose_tissue | 2.00511576 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.90102598 |
| 31 | * MP0004085_abnormal_heartbeat | 1.89060266 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.80927115 |
| 33 | MP0003137_abnormal_impulse_conducting | 1.76519884 |
| 34 | MP0003279_aneurysm | 1.73670563 |
| 35 | MP0005623_abnormal_meninges_morphology | 1.70833092 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.62181965 |
| 37 | MP0005165_increased_susceptibility_to | 1.60842252 |
| 38 | MP0005375_adipose_tissue_phenotype | 1.56024233 |
| 39 | MP0002106_abnormal_muscle_physiology | 1.53928522 |
| 40 | MP0000767_abnormal_smooth_muscle | 1.53636619 |
| 41 | MP0004147_increased_porphyrin_level | 1.53138654 |
| 42 | MP0002254_reproductive_system_inflammat | 1.52687450 |
| 43 | MP0003878_abnormal_ear_physiology | 1.50692884 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.50692884 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.48700573 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.43175776 |
| 47 | * MP0002127_abnormal_cardiovascular_syste | 1.43156927 |
| 48 | MP0002132_abnormal_respiratory_system | 1.42506879 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.41175075 |
| 50 | MP0000343_altered_response_to | 1.40539931 |
| 51 | MP0000678_abnormal_parathyroid_gland | 1.35168752 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.35127205 |
| 53 | MP0001348_abnormal_lacrimal_gland | 1.34730603 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.30191085 |
| 55 | MP0005369_muscle_phenotype | 1.29073422 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.25736470 |
| 57 | MP0000759_abnormal_skeletal_muscle | 1.25445116 |
| 58 | MP0003724_increased_susceptibility_to | 1.24951168 |
| 59 | * MP0002128_abnormal_blood_circulation | 1.24517728 |
| 60 | MP0002269_muscular_atrophy | 1.24301269 |
| 61 | * MP0000266_abnormal_heart_morphology | 1.18944551 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.11780069 |
| 63 | * MP0002925_abnormal_cardiovascular_devel | 1.09394739 |
| 64 | * MP0000249_abnormal_blood_vessel | 1.07082004 |
| 65 | MP0010030_abnormal_orbit_morphology | 1.06381034 |
| 66 | MP0000747_muscle_weakness | 1.04063888 |
| 67 | MP0006054_spinal_hemorrhage | 1.01277213 |
| 68 | MP0004510_myositis | 1.00955698 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.00598746 |
| 70 | * MP0001614_abnormal_blood_vessel | 0.99791694 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.97630538 |
| 72 | * MP0000230_abnormal_systemic_arterial | 0.96361765 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.94994822 |
| 74 | * MP0005595_abnormal_vascular_smooth | 0.94990076 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.93504216 |
| 76 | MP0002971_abnormal_brown_adipose | 0.88202735 |
| 77 | MP0005275_abnormal_skin_tensile | 0.88069638 |
| 78 | MP0002168_other_aberrant_phenotype | 0.87979672 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.87793081 |
| 80 | MP0003195_calcinosis | 0.87721641 |
| 81 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86532266 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86330802 |
| 83 | MP0002108_abnormal_muscle_morphology | 0.85368615 |
| 84 | MP0003122_maternal_imprinting | 0.84890778 |
| 85 | MP0003011_delayed_dark_adaptation | 0.83746236 |
| 86 | MP0010329_abnormal_lipoprotein_level | 0.82542408 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.81464457 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 0.79687605 |
| 89 | MP0001784_abnormal_fluid_regulation | 0.76448109 |
| 90 | MP0001958_emphysema | 0.76307365 |
| 91 | MP0009278_abnormal_bone_marrow | 0.73640533 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.73296188 |
| 93 | * MP0002295_abnormal_pulmonary_circulatio | 0.70043230 |
| 94 | MP0003698_abnormal_male_reproductive | 0.69504866 |
| 95 | MP0001661_extended_life_span | 0.68096244 |
| 96 | MP0004233_abnormal_muscle_weight | 0.67797490 |
| 97 | MP0009115_abnormal_fat_cell | 0.65493520 |
| 98 | MP0003303_peritoneal_inflammation | 0.65091061 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.64735061 |
| 100 | MP0005187_abnormal_penis_morphology | 0.64659987 |
| 101 | MP0005360_urolithiasis | 0.63393373 |
| 102 | MP0009379_abnormal_foot_pigmentation | 0.61356044 |
| 103 | MP0005085_abnormal_gallbladder_physiolo | 0.61059668 |
| 104 | MP0004885_abnormal_endolymph | 0.60786144 |
| 105 | MP0001915_intracranial_hemorrhage | 0.59987904 |
| 106 | MP0008995_early_reproductive_senescence | 0.59042659 |
| 107 | * MP0002118_abnormal_lipid_homeostasis | 0.58797482 |
| 108 | MP0001486_abnormal_startle_reflex | 0.55766013 |
| 109 | MP0003119_abnormal_digestive_system | 0.55249071 |
| 110 | MP0009840_abnormal_foam_cell | 0.54944172 |
| 111 | MP0000613_abnormal_salivary_gland | 0.54385960 |
| 112 | MP0003984_embryonic_growth_retardation | 0.54161008 |
| 113 | MP0001929_abnormal_gametogenesis | 0.53910294 |
| 114 | MP0005388_respiratory_system_phenotype | 0.53772175 |
| 115 | MP0002133_abnormal_respiratory_system | 0.53772175 |
| 116 | MP0000733_abnormal_muscle_development | 0.53316498 |
| 117 | MP0002088_abnormal_embryonic_growth/wei | 0.53194911 |
| 118 | MP0003868_abnormal_feces_composition | 0.52790934 |
| 119 | MP0003091_abnormal_cell_migration | 0.52749440 |
| 120 | MP0008872_abnormal_physiological_respon | 0.52069823 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.51942764 |
| 122 | MP0005266_abnormal_metabolism | 0.51713658 |
| 123 | MP0005334_abnormal_fat_pad | 0.51020826 |
| 124 | MP0005409_darkened_coat_color | 0.49859056 |
| 125 | MP0005365_abnormal_bile_salt | 0.49314849 |
| 126 | MP0003045_fibrosis | 0.49106111 |
| 127 | * MP0005319_abnormal_enzyme/_coenzyme | 0.48150921 |
| 128 | MP0000049_abnormal_middle_ear | 0.48062501 |
| 129 | MP0002909_abnormal_adrenal_gland | 0.47839312 |
| 130 | * MP0005535_abnormal_body_temperature | 0.46468527 |
| 131 | MP0001485_abnormal_pinna_reflex | 0.45926387 |
| 132 | MP0001756_abnormal_urination | 0.45059220 |
| 133 | * MP0003633_abnormal_nervous_system | 0.44456552 |
| 134 | MP0003690_abnormal_glial_cell | 0.44426423 |
| 135 | MP0003935_abnormal_craniofacial_develop | 0.44128590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.47418533 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.69576242 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.66261804 |
| 4 | Atrial fibrillation (HP:0005110) | 5.04527139 |
| 5 | Supraventricular arrhythmia (HP:0005115) | 4.68271416 |
| 6 | Primary atrial arrhythmia (HP:0001692) | 4.66948513 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 4.61079888 |
| 8 | Supraventricular tachycardia (HP:0004755) | 4.46946817 |
| 9 | Increased connective tissue (HP:0009025) | 4.43706447 |
| 10 | Lipoatrophy (HP:0100578) | 4.40498556 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 4.39495405 |
| 12 | Polycythemia (HP:0001901) | 4.15562750 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 4.09081648 |
| 14 | Wrist flexion contracture (HP:0001239) | 4.03452547 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 4.01555945 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.96851083 |
| 17 | Difficulty running (HP:0009046) | 3.90475284 |
| 18 | Syncope (HP:0001279) | 3.75915450 |
| 19 | Abnormality of the hepatic vasculature (HP:0006707) | 3.75798628 |
| 20 | Prolonged QT interval (HP:0001657) | 3.73500822 |
| 21 | Myoglobinuria (HP:0002913) | 3.69579850 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.69172185 |
| 23 | Subaortic stenosis (HP:0001682) | 3.61812921 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.61812921 |
| 25 | Atrioventricular block (HP:0001678) | 3.61631003 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.61161416 |
| 27 | Dilated cardiomyopathy (HP:0001644) | 3.54608482 |
| 28 | Lymphangioma (HP:0100764) | 3.52734439 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.42514591 |
| 30 | Palpitations (HP:0001962) | 3.35882495 |
| 31 | Heart block (HP:0012722) | 3.34480853 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.28039323 |
| 33 | Myotonia (HP:0002486) | 3.27275648 |
| 34 | Bundle branch block (HP:0011710) | 3.26055748 |
| 35 | High pitched voice (HP:0001620) | 3.25805405 |
| 36 | Bulbous nose (HP:0000414) | 3.19687298 |
| 37 | Abnormal atrioventricular conduction (HP:0005150) | 3.14845660 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 3.14215798 |
| 39 | Cerebral aneurysm (HP:0004944) | 3.08199223 |
| 40 | Pigmentary retinal degeneration (HP:0001146) | 3.08017282 |
| 41 | Cerebral hemorrhage (HP:0001342) | 3.06871342 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 3.06126598 |
| 43 | Esophageal varix (HP:0002040) | 3.02145136 |
| 44 | Hematochezia (HP:0002573) | 3.01853272 |
| 45 | Ventricular arrhythmia (HP:0004308) | 3.00274356 |
| 46 | Broad metatarsal (HP:0001783) | 3.00250128 |
| 47 | Ventricular fibrillation (HP:0001663) | 2.95109004 |
| 48 | Difficulty climbing stairs (HP:0003551) | 2.82664984 |
| 49 | Rhabdomyolysis (HP:0003201) | 2.82247743 |
| 50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.81213550 |
| 51 | Nephronophthisis (HP:0000090) | 2.77619628 |
| 52 | Congenital stationary night blindness (HP:0007642) | 2.75532100 |
| 53 | Conjunctival telangiectasia (HP:0000524) | 2.72013666 |
| 54 | Ketoacidosis (HP:0001993) | 2.70875112 |
| 55 | Type II lissencephaly (HP:0007260) | 2.69379117 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.63844439 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.63386749 |
| 58 | Visceral angiomatosis (HP:0100761) | 2.55476175 |
| 59 | Muscle stiffness (HP:0003552) | 2.51221677 |
| 60 | Abnormal EKG (HP:0003115) | 2.46097843 |
| 61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45304829 |
| 62 | Occipital encephalocele (HP:0002085) | 2.41506453 |
| 63 | Adactyly (HP:0009776) | 2.40982769 |
| 64 | Cavernous hemangioma (HP:0001048) | 2.40202734 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 2.40146099 |
| 66 | Hemangiomatosis (HP:0007461) | 2.38530949 |
| 67 | Spinal rigidity (HP:0003306) | 2.32831276 |
| 68 | Hemorrhage of the eye (HP:0011885) | 2.29849532 |
| 69 | Scotoma (HP:0000575) | 2.28972914 |
| 70 | Exotropia (HP:0000577) | 2.28502772 |
| 71 | Capillary hemangiomas (HP:0005306) | 2.27815211 |
| 72 | Attenuation of retinal blood vessels (HP:0007843) | 2.26007329 |
| 73 | Congenital hepatic fibrosis (HP:0002612) | 2.25255447 |
| 74 | Hemiplegia (HP:0002301) | 2.23899213 |
| 75 | Polydipsia (HP:0001959) | 2.23876071 |
| 76 | Abnormal drinking behavior (HP:0030082) | 2.23876071 |
| 77 | Clumsiness (HP:0002312) | 2.21717083 |
| 78 | Acanthosis nigricans (HP:0000956) | 2.21373279 |
| 79 | Chronic hepatic failure (HP:0100626) | 2.21276447 |
| 80 | Abnormality of the vitreous humor (HP:0004327) | 2.20881399 |
| 81 | Absent hand (HP:0004050) | 2.20362264 |
| 82 | Pulmonary artery stenosis (HP:0004415) | 2.19416869 |
| 83 | Pancreatic cysts (HP:0001737) | 2.17411519 |
| 84 | Type 1 muscle fiber predominance (HP:0003803) | 2.17341345 |
| 85 | Aneurysm (HP:0002617) | 2.15072759 |
| 86 | Hyperglycinuria (HP:0003108) | 2.14918381 |
| 87 | Ketosis (HP:0001946) | 2.14653608 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14265485 |
| 89 | Molar tooth sign on MRI (HP:0002419) | 2.13546314 |
| 90 | Abnormality of midbrain morphology (HP:0002418) | 2.13546314 |
| 91 | Testicular atrophy (HP:0000029) | 2.12913767 |
| 92 | Distal lower limb muscle weakness (HP:0009053) | 2.12874968 |
| 93 | Stroke (HP:0001297) | 2.11275088 |
| 94 | Duplicated collecting system (HP:0000081) | 2.08862828 |
| 95 | Dicarboxylic aciduria (HP:0003215) | 2.08629971 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08629971 |
| 97 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.07309217 |
| 98 | Hyperventilation (HP:0002883) | 2.05600559 |
| 99 | Venous insufficiency (HP:0005293) | 2.05444398 |
| 100 | J-shaped sella turcica (HP:0002680) | 2.04065775 |
| 101 | Anterior segment dysgenesis (HP:0007700) | 2.02353004 |
| 102 | Hypoplasia of the iris (HP:0007676) | 2.02050307 |
| 103 | Tubular atrophy (HP:0000092) | 2.01515148 |
| 104 | Facial diplegia (HP:0001349) | 2.01483353 |
| 105 | Pancreatic fibrosis (HP:0100732) | 2.01446128 |
| 106 | Potter facies (HP:0002009) | 2.00648818 |
| 107 | Facial shape deformation (HP:0011334) | 2.00648818 |
| 108 | True hermaphroditism (HP:0010459) | 2.00351548 |
| 109 | Fair hair (HP:0002286) | 2.00325766 |
| 110 | Left ventricular hypertrophy (HP:0001712) | 1.99899568 |
| 111 | Conjunctival hamartoma (HP:0100780) | 1.99613470 |
| 112 | Areflexia of lower limbs (HP:0002522) | 1.98779466 |
| 113 | Hyperkalemia (HP:0002153) | 1.98102406 |
| 114 | Neonatal death (HP:0003811) | 1.97910144 |
| 115 | Absent speech (HP:0001344) | 1.96849404 |
| 116 | Joint hemorrhage (HP:0005261) | 1.96839913 |
| 117 | Neoplasm of the oral cavity (HP:0100649) | 1.95784777 |
| 118 | Porencephaly (HP:0002132) | 1.95040250 |
| 119 | Abnormality of the renal collecting system (HP:0004742) | 1.94274700 |
| 120 | Skull defect (HP:0001362) | 1.94249132 |
| 121 | Abnormality of the nasal mucosa (HP:0000433) | 1.94084011 |
| 122 | Mesangial abnormality (HP:0001966) | 1.89907391 |
| 123 | Palmoplantar keratoderma (HP:0000982) | 1.89806919 |
| 124 | Bone cyst (HP:0012062) | 1.88254698 |
| 125 | Nonimmune hydrops fetalis (HP:0001790) | 1.87837842 |
| 126 | Cystic liver disease (HP:0006706) | 1.85848016 |
| 127 | Congestive heart failure (HP:0001635) | 1.85285005 |
| 128 | Deep venous thrombosis (HP:0002625) | 1.85272017 |
| 129 | Hyperammonemia (HP:0001987) | 1.84368933 |
| 130 | Increased muscle lipid content (HP:0009058) | 1.84355180 |
| 131 | Subcapsular cataract (HP:0000523) | 1.84016179 |
| 132 | Decreased circulating renin level (HP:0003351) | 1.83640822 |
| 133 | Hypoalphalipoproteinemia (HP:0003233) | 1.82652038 |
| 134 | Hip contracture (HP:0003273) | 1.82346649 |
| 135 | Hepatic necrosis (HP:0002605) | 1.81136120 |
| 136 | Hypoplastic ischia (HP:0003175) | 1.81112406 |
| 137 | Sudden cardiac death (HP:0001645) | 1.80235825 |
| 138 | Muscular dystrophy (HP:0003560) | 1.79570976 |
| 139 | Abnormality of femoral epiphyses (HP:0006499) | 1.79094709 |
| 140 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.79094709 |
| 141 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78861471 |
| 142 | Absent/shortened dynein arms (HP:0200106) | 1.78861471 |
| 143 | Dysautonomia (HP:0002459) | 1.78405033 |
| 144 | Large for gestational age (HP:0001520) | 1.78121878 |
| 145 | Portal hypertension (HP:0001409) | 1.78040269 |
| 146 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.77457406 |
| 147 | Protrusio acetabuli (HP:0003179) | 1.74521595 |
| 148 | Birth length less than 3rd percentile (HP:0003561) | 1.74460701 |
| 149 | Ulnar claw (HP:0001178) | 1.74316768 |
| 150 | Abnormal urine output (HP:0012590) | 1.73848380 |
| 151 | Hamartoma of the eye (HP:0010568) | 1.72973029 |
| 152 | Asymmetry of the thorax (HP:0001555) | 1.72853061 |
| 153 | Large hands (HP:0001176) | 1.72741475 |
| 154 | Generalized muscle weakness (HP:0003324) | 1.72015886 |
| 155 | Limb-girdle muscle atrophy (HP:0003797) | 1.71916234 |
| 156 | Stage 5 chronic kidney disease (HP:0003774) | 1.71348494 |
| 157 | Ileus (HP:0002595) | 1.69910879 |
| 158 | Abnormality of the renal cortex (HP:0011035) | 1.69804097 |
| 159 | Polyuria (HP:0000103) | 1.69571948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.61012745 |
| 2 | KDR | 5.78266245 |
| 3 | TTN | 2.97284730 |
| 4 | TGFBR2 | 2.96654042 |
| 5 | MYLK | 2.78012714 |
| 6 | FRK | 2.47951057 |
| 7 | TRIB3 | 2.41572298 |
| 8 | RIPK1 | 2.32854644 |
| 9 | PKN2 | 2.06450609 |
| 10 | PDK2 | 2.04659596 |
| 11 | FES | 2.01553052 |
| 12 | LMTK2 | 2.01079245 |
| 13 | DMPK | 1.87058914 |
| 14 | PHKG2 | 1.78004758 |
| 15 | PHKG1 | 1.78004758 |
| 16 | PDK3 | 1.77872874 |
| 17 | PDK4 | 1.77872874 |
| 18 | BCKDK | 1.77572043 |
| 19 | EPHB2 | 1.57412327 |
| 20 | OBSCN | 1.57331003 |
| 21 | GRK1 | 1.47749377 |
| 22 | INSRR | 1.42354533 |
| 23 | TGFBR1 | 1.37710867 |
| 24 | TEC | 1.36296714 |
| 25 | BMPR1B | 1.34705507 |
| 26 | MAPK12 | 1.30851386 |
| 27 | PRKD1 | 1.25026730 |
| 28 | MAP2K3 | 1.20335192 |
| 29 | CAMK1D | 1.18393246 |
| 30 | NTRK3 | 1.14837093 |
| 31 | FER | 1.10142322 |
| 32 | PTK6 | 1.08841203 |
| 33 | PRKD3 | 1.06126852 |
| 34 | ERN1 | 1.03909699 |
| 35 | PLK4 | 0.99926135 |
| 36 | CAMK1G | 0.98308119 |
| 37 | PDGFRA | 0.98231674 |
| 38 | FGFR2 | 0.92714825 |
| 39 | MAP3K3 | 0.92574088 |
| 40 | WNK4 | 0.90876849 |
| 41 | PIK3CA | 0.89335463 |
| 42 | PAK3 | 0.81908426 |
| 43 | DAPK2 | 0.79988583 |
| 44 | ILK | 0.79870521 |
| 45 | EPHB1 | 0.78434934 |
| 46 | SIK1 | 0.78337391 |
| 47 | EEF2K | 0.77430192 |
| 48 | ADRBK2 | 0.75772677 |
| 49 | NME1 | 0.74871773 |
| 50 | PINK1 | 0.72429643 |
| 51 | MAPK15 | 0.71895177 |
| 52 | ACVR1B | 0.71039308 |
| 53 | STK24 | 0.66621719 |
| 54 | MAPKAPK3 | 0.65672625 |
| 55 | AKT3 | 0.65648671 |
| 56 | ROCK1 | 0.65199164 |
| 57 | FGFR4 | 0.64898255 |
| 58 | ZAP70 | 0.64822162 |
| 59 | MAPK7 | 0.64063374 |
| 60 | MAP3K7 | 0.63079099 |
| 61 | EPHA3 | 0.61975658 |
| 62 | NEK1 | 0.61083523 |
| 63 | STK38L | 0.60946630 |
| 64 | PRKCH | 0.60918551 |
| 65 | PLK2 | 0.56948729 |
| 66 | * PRKAA2 | 0.56031728 |
| 67 | NLK | 0.55622273 |
| 68 | PDPK1 | 0.54159337 |
| 69 | PAK4 | 0.53577773 |
| 70 | NTRK1 | 0.53051920 |
| 71 | OXSR1 | 0.52833773 |
| 72 | MAP4K2 | 0.52438146 |
| 73 | MET | 0.52405890 |
| 74 | DAPK3 | 0.51479824 |
| 75 | PTK2 | 0.51457971 |
| 76 | CAMK2D | 0.51110173 |
| 77 | STK39 | 0.49766818 |
| 78 | PIK3CG | 0.48761246 |
| 79 | PAK2 | 0.47860160 |
| 80 | CAMK4 | 0.47161186 |
| 81 | * PTK2B | 0.46908756 |
| 82 | MAP4K1 | 0.45626557 |
| 83 | FGFR3 | 0.45268577 |
| 84 | PRKCE | 0.44428025 |
| 85 | CAMK1 | 0.44378976 |
| 86 | RET | 0.44100540 |
| 87 | RPS6KA2 | 0.42328773 |
| 88 | GRK7 | 0.42247522 |
| 89 | GSK3A | 0.41987525 |
| 90 | CDC42BPA | 0.41973315 |
| 91 | MAP2K2 | 0.41330004 |
| 92 | TNK2 | 0.40870913 |
| 93 | MAP3K11 | 0.40784909 |
| 94 | * PRKAA1 | 0.39823578 |
| 95 | MAP3K1 | 0.38142260 |
| 96 | ITK | 0.36877205 |
| 97 | MAP2K1 | 0.36731805 |
| 98 | IGF1R | 0.36711251 |
| 99 | MUSK | 0.35511677 |
| 100 | MAPK13 | 0.34731392 |
| 101 | BMX | 0.34262414 |
| 102 | PKN1 | 0.33251817 |
| 103 | HCK | 0.32883050 |
| 104 | MAP2K6 | 0.32828461 |
| 105 | TNIK | 0.31075694 |
| 106 | ADRBK1 | 0.30969292 |
| 107 | PRKACB | 0.30477308 |
| 108 | ICK | 0.30438714 |
| 109 | MTOR | 0.30232943 |
| 110 | WNK1 | 0.30027343 |
| 111 | CAMK2A | 0.29555932 |
| 112 | PDK1 | 0.29153946 |
| 113 | LRRK2 | 0.28821930 |
| 114 | JAK3 | 0.28429842 |
| 115 | MARK2 | 0.27764045 |
| 116 | MAPKAPK5 | 0.27593898 |
| 117 | PDGFRB | 0.27532870 |
| 118 | MST4 | 0.27053749 |
| 119 | AKT2 | 0.27008503 |
| 120 | * SRC | 0.26801189 |
| 121 | PRKG1 | 0.26654736 |
| 122 | ROCK2 | 0.26618193 |
| 123 | * PRKACG | 0.25218397 |
| 124 | PRKD2 | 0.24095290 |
| 125 | EGFR | 0.23961569 |
| 126 | BTK | 0.23703764 |
| 127 | STK11 | 0.23692923 |
| 128 | TAOK3 | 0.23244472 |
| 129 | JAK2 | 0.21601070 |
| 130 | STK38 | 0.21131040 |
| 131 | TRPM7 | 0.20815850 |
| 132 | MAP3K6 | 0.20501794 |
| 133 | FLT3 | 0.20337629 |
| 134 | MAP2K4 | 0.19985843 |
| 135 | SGK2 | 0.19761825 |
| 136 | CSK | 0.19696214 |
| 137 | INSR | 0.19281599 |
| 138 | * PRKACA | 0.19049364 |
| 139 | BRSK2 | 0.19040848 |
| 140 | RPS6KC1 | 0.19029998 |
| 141 | NEK2 | 0.18783060 |
| 142 | RPS6KA6 | 0.18474802 |
| 143 | EPHA2 | 0.17206106 |
| 144 | STK3 | 0.17013199 |
| 145 | MAPK1 | 0.16204245 |
| 146 | SGK223 | 0.15715343 |
| 147 | SGK494 | 0.15715343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.16193855 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.56205461 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.26093917 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.02336939 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.93730402 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71246419 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.56732003 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.56678932 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.29198201 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28372985 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23797786 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.22712259 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09536821 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.01559418 |
| 15 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.98363188 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.95686830 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.93799445 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92285731 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84022052 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.79303579 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.73426651 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.71914608 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63478211 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62704680 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62059946 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.62033652 |
| 27 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.61977157 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.53623614 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47669719 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46493662 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42912596 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40460894 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36755737 |
| 34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.33605537 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.32482646 |
| 36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.30415075 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28108635 |
| 38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.27039256 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 1.26839432 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25885643 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25628507 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.23989699 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22333065 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22027057 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20559369 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 1.17232566 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16957981 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 1.13841599 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10542456 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09441695 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08471723 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07860075 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 1.06057466 |
| 54 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03906688 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03551623 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03304456 |
| 57 | * Insulin resistance_Homo sapiens_hsa04931 | 1.02605363 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01949796 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00670033 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.97732697 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97617690 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94907118 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94878426 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94846045 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92802447 |
| 66 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88809672 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88667183 |
| 68 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88550286 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87059988 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86476836 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86201594 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86021498 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.86019571 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85305764 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83883212 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83580764 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79901267 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79733435 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79052658 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78603382 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76099956 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75258802 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74280358 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74119848 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73872376 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73869930 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73769070 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.70492950 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69742831 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68447813 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66179931 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65792165 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.65615297 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64942718 |
| 95 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64558945 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.64468000 |
| 97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63664262 |
| 98 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63539931 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63246077 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61568578 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61238472 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59898848 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59845937 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59740019 |
| 105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58948045 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58560886 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58429106 |
| 108 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58357661 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.58143786 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57940489 |
| 111 | Insulin secretion_Homo sapiens_hsa04911 | 0.57304057 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55788539 |
| 113 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55664507 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54787672 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52310791 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52184212 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50115546 |
| 118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49894368 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49814250 |
| 120 | Malaria_Homo sapiens_hsa05144 | 0.49737786 |
| 121 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49333231 |
| 122 | * Platelet activation_Homo sapiens_hsa04611 | 0.48984470 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.48886483 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47653308 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.47373926 |
| 126 | Salivary secretion_Homo sapiens_hsa04970 | 0.45766337 |
| 127 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44013775 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43124857 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43021707 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42277643 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41888439 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41855592 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41790386 |
| 134 | Melanogenesis_Homo sapiens_hsa04916 | 0.41460145 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40933667 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40517136 |
| 137 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39864877 |
| 138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38218731 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36752565 |
| 140 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35943850 |
| 141 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35935627 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35235274 |
| 143 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34047120 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33698195 |
| 145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33622700 |
| 146 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30499831 |
| 147 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29741935 |

